Related by context. Frequent words. (Click for all words.) 73 RECIST criteria 70 patients evaluable 69 evaluable patients 66 RECIST 65 evaluable 64 cytogenetic response 63 distant metastasis 62 median PFS 61 plus dexamethasone 61 free survival PFS 61 mg kg dose 60 confidence interval #.#-#.# 60 chemoradiotherapy 59 CMV disease 59 P = .# 59 FOLFOX 59 distant metastases 59 neoadjuvant chemotherapy 59 tumor regression 58 tumor recurrence 58 lymph node involvement 58 plus methotrexate 58 febrile neutropenia 58 lymphopenia 58 antibody titers 58 virologic failure 58 FOLFIRI 58 mg BID 58 breast carcinoma 58 ≥ 57 Median survival 57 sustained virologic response 57 laboratory abnormalities 57 XELOX 57 KRAS mutations 57 chemoradiation 57 confidence interval CI 56 tumor shrinkage 56 % CI #.#-#.# [006] 56 virologic response 56 CMV infection 56 dose cohorts 56 mycophenolate mofetil 56 nephrectomy 56 neoadjuvant therapy 56 endophthalmitis 56 CI #.#-#.# [002] 55 lymph node metastases 55 PCa 55 adalimumab 55 thromboembolic events 55 vertebral fracture 55 plus gemcitabine 55 androgen deprivation 55 pheochromocytoma 55 viremia 55 neoadjuvant 55 events SAEs 55 dacarbazine 55 estimated glomerular filtration 55 histologic 55 metastatic renal cell carcinoma 55 statistically significant p = 55 annualized relapse 55 tumor resection 55 serum concentrations 55 EBRT 55 malignant lesions 55 cystectomy 55 n = 55 Secondary endpoints include 55 cabazitaxel 55 patients receiving ERBITUX 55 mcg dose 55 PRECiSE 54 tumor lysis syndrome 54 HSCT 54 mg QD 54 coinfected 54 discontinuations due 54 Secondary endpoints included 54 Postoperative 54 nonresponders 54 liver metastases 54 leukopenia 54 adjuvant chemotherapy 54 fibrinolysis 54 mcg kg 54 peginterferon 54 univariate 54 LVEF 54 seroconversion 54 intracerebral hemorrhage 54 cardiac dysfunction 54 histologically 54 log# 54 pg mL 54 thromboembolism 53 mitoxantrone 53 Recurrence 53 HCV genotype 1